JP2018158941A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018158941A5 JP2018158941A5 JP2018119810A JP2018119810A JP2018158941A5 JP 2018158941 A5 JP2018158941 A5 JP 2018158941A5 JP 2018119810 A JP2018119810 A JP 2018119810A JP 2018119810 A JP2018119810 A JP 2018119810A JP 2018158941 A5 JP2018158941 A5 JP 2018158941A5
- Authority
- JP
- Japan
- Prior art keywords
- chloro
- ethyl
- hydrogen
- methyl
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 16
- 229910052739 hydrogen Inorganic materials 0.000 claims 13
- 239000001257 hydrogen Substances 0.000 claims 13
- 150000002431 hydrogen Chemical class 0.000 claims 11
- 150000001875 compounds Chemical class 0.000 claims 7
- 150000003839 salts Chemical class 0.000 claims 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 5
- 208000035143 Bacterial infection Diseases 0.000 claims 4
- 208000022362 bacterial infectious disease Diseases 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- -1 4- (trifluoromethoxy) phenyl Chemical group 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- QXKHYNVANLEOEG-UHFFFAOYSA-N Methoxsalen Chemical group C1=CC(=O)OC2=C1C=C1C=COC1=C2OC QXKHYNVANLEOEG-UHFFFAOYSA-N 0.000 claims 2
- 201000008827 tuberculosis Diseases 0.000 claims 2
- JNYLMODTPLSLIF-UHFFFAOYSA-N 6-(trifluoromethyl)pyridine-3-carboxylic acid Chemical group OC(=O)C1=CC=C(C(F)(F)F)N=C1 JNYLMODTPLSLIF-UHFFFAOYSA-N 0.000 claims 1
- 125000001246 bromo group Chemical group Br* 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361861750P | 2013-08-02 | 2013-08-02 | |
| US61/861,750 | 2013-08-02 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016530547A Division JP2016525562A (ja) | 2013-08-02 | 2014-08-01 | 抗感染症化合物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019077088A Division JP2019131606A (ja) | 2013-08-02 | 2019-04-15 | 抗感染症化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018158941A JP2018158941A (ja) | 2018-10-11 |
| JP2018158941A5 true JP2018158941A5 (cg-RX-API-DMAC7.html) | 2019-05-30 |
| JP6757768B2 JP6757768B2 (ja) | 2020-09-23 |
Family
ID=51260879
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016530547A Withdrawn JP2016525562A (ja) | 2013-08-02 | 2014-08-01 | 抗感染症化合物 |
| JP2018119810A Active JP6757768B2 (ja) | 2013-08-02 | 2018-06-25 | 抗感染症化合物 |
| JP2019077088A Pending JP2019131606A (ja) | 2013-08-02 | 2019-04-15 | 抗感染症化合物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016530547A Withdrawn JP2016525562A (ja) | 2013-08-02 | 2014-08-01 | 抗感染症化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019077088A Pending JP2019131606A (ja) | 2013-08-02 | 2019-04-15 | 抗感染症化合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20160185774A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3027615B1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP2016525562A (cg-RX-API-DMAC7.html) |
| KR (1) | KR102292293B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN105745208A (cg-RX-API-DMAC7.html) |
| DK (1) | DK3027615T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2883565T3 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE056198T2 (cg-RX-API-DMAC7.html) |
| PH (1) | PH12016500207A1 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2734760C2 (cg-RX-API-DMAC7.html) |
| SG (1) | SG11201600686QA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2015014993A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108235704B (zh) | 2015-07-02 | 2021-10-26 | 爱尔兰詹森科学公司 | 抗细菌化合物 |
| PE20181352A1 (es) * | 2015-09-17 | 2018-08-22 | Marvin J Miller | Compuestos heterociclicos que contienen bencilamina y composiciones utiles contra infeccion por micobacterias |
| MA45377A (fr) | 2016-06-16 | 2019-04-24 | Janssen Sciences Ireland Unlimited Co | Composés hétérocycliques en tant qu'agents antibacteriens |
| BR112018075939A2 (pt) * | 2016-06-16 | 2019-04-09 | Janssen Sciences Ireland Unlimited Company | compostos heterocíclicos como antibacterianos |
| EP4417262A3 (en) | 2017-03-01 | 2024-11-27 | Janssen Sciences Ireland Unlimited Company | Combination therapy |
| JP7233059B2 (ja) * | 2017-10-05 | 2023-03-06 | キュアテック バイオ アーベー | 結核に対する薬剤と組み合わせた環融合型チアゾリノ２－ピリドン |
| CN108101828B (zh) * | 2018-01-15 | 2021-05-04 | 西华师范大学 | 3-吲哚基甲酰胺类化合物及其制备方法 |
| CN108159049B (zh) * | 2018-02-01 | 2021-01-05 | 中国科学院广州生物医药与健康研究院 | 一种吡啶类化合物的新用途 |
| AU2019387370A1 (en) | 2018-11-30 | 2021-06-10 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
| JP2022081710A (ja) * | 2019-03-29 | 2022-06-01 | ユーティアイ リミテッド パートナーシップ | 関節リウマチを治療するためのｔ型カルシウムチャネル阻害剤の使用 |
| WO2020203609A1 (ja) * | 2019-03-29 | 2020-10-08 | 日本ケミファ株式会社 | 掻痒を治療するためのｔ型カルシウムチャネル阻害剤の使用 |
| TWI861208B (zh) | 2019-09-10 | 2024-11-11 | 日商鹽野義製藥股份有限公司 | 對分枝桿菌感染有用之含苄胺的 5,6-雜芳族化合物 |
| ES2978573T3 (es) | 2019-09-13 | 2024-09-16 | Janssen Sciences Ireland Unlimited Co | Compuestos antibacterianos |
| CA3149988A1 (en) * | 2019-09-30 | 2021-04-08 | Jerome Emile Georges Guillemont | 4-QUINOLINONE ANTIBACTERIAL COMPOUNDS |
| MX2022003816A (es) * | 2019-09-30 | 2022-05-06 | Janssen Sciences Ireland Unlimited Co | Compuestos antibacterianos. |
| KR102381397B1 (ko) * | 2020-07-10 | 2022-03-30 | 경희대학교 산학협력단 | 신규 나프토퀴논 유도체 화합물 및 이를 포함하는 항균용 조성물 |
| WO2022194803A1 (en) | 2021-03-16 | 2022-09-22 | Janssen Sciences Ireland Unlimited Company | Antibacterial compounds |
| BR112023018655A2 (pt) | 2021-03-17 | 2023-12-12 | Janssen Sciences Ireland Unlimited Co | Compostos antibacterianos |
| WO2022194906A1 (en) | 2021-03-17 | 2022-09-22 | Janssen Sciences Ireland Unlimited Company | Antibacterial compounds |
| KR20240090864A (ko) | 2021-10-28 | 2024-06-21 | 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 | 세균성 감염의 치료에 사용하기 위한 이미다조피리딘 아미드 및 관련 화합물 |
| WO2024089170A1 (en) | 2022-10-27 | 2024-05-02 | Janssen Sciences Ireland Unlimited Company | Antibacterial compounds |
| WO2024223859A1 (en) | 2023-04-26 | 2024-10-31 | Janssen Pharmaceutica Nv | Antibacterial compounds |
| WO2025017047A1 (en) | 2023-07-18 | 2025-01-23 | Janssen Pharmaceutica Nv | Combination products of at least three antibiotics comprising bedaquiline, pretomanid or delamanid, and a cytochrome bc1 inhibitor, and their use in the treatment of mycobacterial infections |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2906250B1 (fr) * | 2006-09-22 | 2008-10-31 | Sanofi Aventis Sa | Derives de 2-aryl-6phenyl-imidazo(1,2-a) pyridines, leur preparation et leur application en therapeutique |
| CA2672960A1 (en) * | 2006-12-20 | 2008-07-10 | Schering Corporation | Novel jnk inhibitors |
| WO2009140101A2 (en) * | 2008-05-12 | 2009-11-19 | Boehringer Ingelheim International Gmbh | Imidazopyridine compounds useful as mmp-13 inhibitors |
| EP3257854A1 (en) * | 2009-11-05 | 2017-12-20 | University of Notre Dame du Lac | Imidazo[1,2-a]pyridine compounds, synthesis thereof, and methods of using same |
| CA2793086C (en) * | 2010-03-18 | 2018-08-21 | Institut Pasteur Korea | Substituted imidazo[1,2-a]pyridine compounds and their use in the treatment of bacterial infections |
| KR102104125B1 (ko) * | 2011-04-21 | 2020-05-29 | 재단법인 한국파스퇴르연구소 | 소염 화합물 |
| CN103324035B (zh) * | 2013-06-20 | 2015-07-01 | 深圳市华星光电技术有限公司 | 掩膜板和阵列基板的制作方法 |
-
2014
- 2014-08-01 US US14/909,663 patent/US20160185774A1/en not_active Abandoned
- 2014-08-01 KR KR1020167005457A patent/KR102292293B1/ko active Active
- 2014-08-01 ES ES14745158T patent/ES2883565T3/es active Active
- 2014-08-01 WO PCT/EP2014/066614 patent/WO2015014993A2/en not_active Ceased
- 2014-08-01 HU HUE14745158A patent/HUE056198T2/hu unknown
- 2014-08-01 JP JP2016530547A patent/JP2016525562A/ja not_active Withdrawn
- 2014-08-01 SG SG11201600686QA patent/SG11201600686QA/en unknown
- 2014-08-01 EP EP14745158.7A patent/EP3027615B1/en active Active
- 2014-08-01 CN CN201480054331.1A patent/CN105745208A/zh active Pending
- 2014-08-01 DK DK14745158.7T patent/DK3027615T3/da active
- 2014-08-01 RU RU2016107378A patent/RU2734760C2/ru active
- 2014-08-01 CN CN201811384685.9A patent/CN109575018A/zh active Pending
-
2016
- 2016-01-29 PH PH12016500207A patent/PH12016500207A1/en unknown
-
2018
- 2018-06-25 JP JP2018119810A patent/JP6757768B2/ja active Active
-
2019
- 2019-04-15 JP JP2019077088A patent/JP2019131606A/ja active Pending